Intelligence Platform

Patents

Browse 2,465 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 8680083

Controlled release corticosteroid compositions and methods for the treatment of otic disor

The Regents of the University of California · Granted Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8680082

Controlled release corticosteroid compositions and methods for the treatment of otic disor

The Regents of the University of California · Granted Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8679545

Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal

The Regents of the University of California · Granted Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8679510

Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamy

The Regents of the University of California · Granted Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8674118

Compounds and methods for the treatment or prevention of flavivirus infections

Vertex Pharmaceuticals Incorporated · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8673897

Benzodiazepinone compounds and methods of treatment using same

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8673887

Non-hormonal steroid modulators of NF-kB for treatment of disease

ReveraGen BioPharma, Inc. · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8669258

Treatment for gastroparesis using sepiapterin

The Board of Regents of the University of Texas System · Granted Tue Mar 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8664273

Treatment of hepatitis C virus with telaprevir (VX-950) in patients non-responsive to trea

Vertex Pharmaceuticals Incorporated · Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8664251

Ryanodine receptor inhibitors for treatment of T-cell mediated disorders

The Regents of the University of California · Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8663987

Mesenchymal stem cells for the treatment of CNS diseases

BRAINSTORM CELL THERAPEUTICS LTD. · Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8663649

Diagnosis and treatment of Trypanosoma cruzi infection and Chagas disease

The Board of Regents of the University of Texas System · Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8658787

Galacto-rhamnogalacturonate compositions for the treatment of non-alcoholic steatohepatiti

GALECTIN THERAPEUTICS, INC. · Granted Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8658674

Thiophene analogues for the treatment or prevention of flavivirus infections

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8658627

Pregnancy hormone combination for treatment of autoimmune diseases

The Regents of the University of California · Granted Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8658626

Controlled release corticosteroid compositions and methods for the treatment of otic disor

The Regents of the University of California · Granted Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8658616

Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of h

University College Cardiff Consultants Limited · Granted Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8653027

Method of treatment of type-1 diabetes with humanin analogues

The Regents of the University of California · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8648100

Roflumilast for the treatment of pulmonary hypertension

TAKEDA GMBH · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8648119

Controlled release immunomodulator compositions and methods for the treatment of otic diso

The Regents of the University of California · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8648102

Compounds for treatment of cell proliferative diseases

The Board of Regents of the University of Texas System · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8642282

Inhibitors of nitric oxide synthase for treatment of melanoma

The Regents of the University of California · Granted Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8637560

Imidazolidinone compounds, methods to inhibit deubiquitination and methods of treatment

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8637538

Methods for treatment of pruritis

Trevi Therapeutics, Inc. · Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted